HBK Investments’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-42,900
| Closed | -$121K | – | 1281 |
|
|
2018
Q2 | $121K | Buy |
+42,900
| New | +$121K | ﹤0.01% | 904 |
|
|
2018
Q1 | – | Sell |
-14,300
| Closed | -$41K | – | 1152 |
|
|
2017
Q4 | $41K | Buy |
+14,300
| New | +$41K | ﹤0.01% | 882 |
|
|
2017
Q2 | – | Sell |
-62,863
| Closed | -$265K | – | 1000 |
|
|
2017
Q1 | $265K | Sell |
62,863
-539,326
| -90% | -$2.27M | ﹤0.01% | 533 |
|
|
2016
Q4 | $2.49M | Buy |
602,189
+226,589
| +60% | +$936K | 0.02% | 245 |
|
|
2016
Q3 | $3.04M | Buy |
375,600
+247,500
| +193% | +$2M | 0.03% | 236 |
|
|
2016
Q2 | $999K | Buy |
128,100
+69,100
| +117% | +$539K | 0.01% | 510 |
|
|
2016
Q1 | $455K | Buy |
+59,000
| New | +$455K | ﹤0.01% | 692 |
|
|
2015
Q2 | – | Sell |
-116,106
| Closed | -$1.15M | – | 1094 |
|
|
2015
Q1 | $1.15M | Buy |
+116,106
| New | +$1.15M | 0.01% | 459 |
|
|
2014
Q4 | – | Sell |
-207,100
| Closed | -$2.07M | – | 1110 |
|
|
2014
Q3 | $2.07M | Buy |
+207,100
| New | +$2.07M | 0.03% | 312 |
|
|
2013
Q3 | – | Sell |
-79,700
| Closed | -$652K | – | 969 |
|
|
2013
Q2 | $652K | Buy |
+79,700
| New | +$652K | 0.01% | 481 |
|